Hypobetalipoproteinemia: genetics, biochemistry, and clinical spectrum, Adv. Clin. Chem, vol.54, pp.81-107, 2011. ,
Update on primary hypobetalipoproteinemia, Curr. Atheroscler. Rep, vol.16, p.423, 2014. ,
Insights from human congenital disorders of intestinal lipid metabolism, J. Lipid Res, vol.56, pp.945-962, 2015. ,
Cloning and gene defects in microsomal triglyceride transfer protein associated with abetalipoproteinaemia, Nature, vol.365, pp.65-69, 1993. ,
Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein, Hum. Mol. Genet, vol.2, pp.2109-2116, 1993. ,
Mutations in a Sar1 GTPase of COPII vesicles are associated with lipid absorption disorders, Nat. Genet, vol.34, pp.29-31, 2003. ,
Homozygous MTTP and APOB mutations may lead to hepatic steatosis and fibrosis despite metabolic differences in congenital hypocholesterolemia, J. Hepatol, vol.61, pp.891-902, 2014. ,
URL : https://hal.archives-ouvertes.fr/hal-01859387
Abetalipoproteinemia: two case reports and literature review, Orphanet J. Rare Dis, vol.3, p.19, 2008. ,
Long-term management of abetalipoproteinaemia. Possible role for vitamin E, Arch. Dis. Child, vol.52, pp.209-214, 1977. ,
Effect of large oral doses of vitamin E on the neurological sequelae of patients with abetalipoproteinemia, Ann. N. Y. Acad. Sci, vol.393, pp.133-144, 1982. ,
Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia, Br. J. Ophthalmol, vol.70, pp.166-173, 1986. ,
Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients, Eye (Lond.), vol.15, pp.525-530, 2001. ,
Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis, Gastroenterology, vol.104, pp.1727-1735, 1993. ,
Bioavailability of a novel, water-soluble vitamin E formulation in malabsorbing patients, Dig. Dis. Sci, vol.52, pp.347-352, 2007. ,
Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis, J. Clin. Pharm. Ther, vol.34, pp.515-522, 2009. ,
The measurement of nanograms of tocopherol from needle aspiration biopsies of adipose tissue: normal and abetalipoproteinemic subjects, J. Lipid Res, vol.24, pp.652-656, 1983. ,
Red cell content of vitamin E and fatty acids in normal subjects and patients with abnormal lipid metabolism, Int. Z. Vitaminforsch, vol.40, pp.344-350, 1970. ,
A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood, J. Lipid Res, vol.20, pp.639-645, 1979. ,
Establishment of reference values of alpha-tocopherol in plasma, red blood cells and adipose tissue in healthy children to improve the management of chylomicron retention disease, a rare genetic hypocholesterolemia, Orphanet J. Rare Dis, vol.11, p.114, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01850299
Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases, Eur. J. Pediatr, vol.168, pp.983-989, 2009. ,
Anderson or chylomicron retention disease: molecular impact of five mutations in the SAR1B gene on the structure and the functionality of Sar1b protein, Mol. Genet. Metab, vol.93, pp.74-84, 2008. ,
The role of vitamin E in the treatment of the neurological features of abetalipoproteinaemia and other disorders of fat absorption, J. Inherit. Metab. Dis, vol.8, issue.1, pp.88-92, 1985. ,
Guidelines for the diagnosis and management of chylomicron retention disease based on a review of the literature and the experience of two centers, Orphanet J. Rare Dis, vol.5, p.24, 2010. ,
URL : https://hal.archives-ouvertes.fr/inserm-00654377
Overview of the in vitro stability of commonly measured vitamins and carotenoids in whole blood, Ann. Clin. Biochem, vol.52, pp.259-269, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01601143
Simultaneous measurement of seven carotenoids, retinol and alphatocopherol in serum by high-performance liquid chromatography, J. Chromatogr. B Biomed. Sci. Appl, vol.694, pp.71-81, 1997. ,
Simultaneous determination of alpha-tocopherol and retinol in plasma or red cells by high pressure liquid chromatography, Am. J. Clin. Nutr, vol.32, pp.2143-2149, 1979. ,
Allometry is a reasonable choice in pediatric drug development, J. Clin. Pharmacol, vol.57, pp.469-475, 2017. ,
A pharmacokinetic standard for babies and adults, J. Pharm. Sci, vol.102, pp.2941-2952, 2013. ,
, NONMEM User's Guides, 1989.
Anderson's disease (chylomicron retention disease): a new mutation in the SARA2 gene associated with muscular and cardiac abnormalities, Clin. Genet, vol.74, pp.546-552, 2008. ,
Discrimination between RRR-and all-racemic-alpha-tocopherols labeled with deuterium by patients with abetalipoproteinemia, Atherosclerosis, vol.108, pp.27-37, 1994. ,
Plasma alpha-tocopherol concentrations after supplementation with water-and fat-soluble vitamin E, Am. J. Clin. Nutr, vol.64, pp.329-335, 1996. ,
Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy, N. Engl. J. Med, vol.317, pp.262-265, 1987. ,
Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids, J. Pediatr. Gastroenterol. Nutr, vol.24, pp.189-193, 1997. ,
Vitamin E: who needs it? II. Diseases associated with vitamin E deficiency, Ohio State Med. J, vol.69, pp.830-833, 1973. ,
Efficacy of water-soluble vitamin E in the treatment of vitamin E malabsorption in short-bowel syndrome, Am. J. Clin. Nutr, vol.59, pp.1270-1274, 1994. ,
Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia, FASEB J, vol.27, pp.2855-2861, 2013. ,
URL : https://hal.archives-ouvertes.fr/hal-01889290
Anderson's disease/chylomicron retention disease and mutations in the SAR1B gene, Mutations in, pp.251-272, 2012. ,
Apolipoprotein B48 glycosylation in abetalipoproteinemia and Anderson's disease, Gastroenterology, vol.121, pp.1101-1108, 2001. ,
Hypobetalipoproteinemia with accumulation of an apoprotein B-like protein in intestinal cells. Immunoenzymatic and biochemical characterization of seven cases of Anderson's disease, J. Clin. Invest, vol.78, pp.398-410, 1986. ,
Malabsorption, hypocholesterolemia, and fat-filled enterocytes with increased intestinal apoprotein B. Chylomicron retention disease, Gastroenterology, vol.92, pp.390-399, 1987. ,
Molecular analysis and intestinal expression of SAR1 genes and proteins in Anderson's disease (Chylomicron retention disease), Orphanet J. Rare Dis, vol.6, p.1, 2011. ,
Effect of hydrosoluble vitamin E on erythrocyte membrane lipid composition in patients with advanced cirrhosis: an open-label pilot trial, Hepatol. Res, vol.45, pp.890-897, 2015. ,